공시 • Jan 13
Clariant AG to Report Q3, 2026 Results on Nov 03, 2026 Clariant AG announced that they will report Q3, 2026 results on Nov 03, 2026 공시 • Dec 20
CMV Química, C.A. acquired Clariant Venezuela S.A. from Clariant AG (SWX:CLN) for CHF 1.4 million. CMV Química, C.A. acquired Clariant Venezuela S.A. from Clariant AG (SWX:CLN) for CHF 1.4 million on December 19, 2025. For the period ending December 31, 2024, Clariant Venezuela S.A. reported total revenue of CHF 3 million and employed around 60 people..
CMV Química, C.A. completed the acquisition of Clariant Venezuela S.A. from Clariant AG (SWX:CLN) for CHF 1.4 million on December 19, 2025. 공시 • Dec 01
Clariant AG Announces Executive and Board Committee Changes Clariant announced a planned leadership transition within its Business Unit Care Chemicals upon the retirement of Christian Vang in 2026. Marcelo Lu will join Clariant in January 2026 as President Designate for Care Chemicals & Americas and will be a member of the Executive Steering Committee. For the first six months, he will be based at Clariant’s global headquarters in Pratteln, Switzerland, where he will contribute to Group-level priorities and collaborate closely with senior leaders across the organization. During this period, Christian Vang will continue to lead Care Chemicals as President, ensuring continuity and focus on strategic goals. Marcelo Lu launched his career at BASF in 2006 and has held various commercial and general management positions in Germany, Hong Kong, Canada, the U.S and Singapore. His roles included serving as the President of BASF Canada Inc. from 2016 to 2021, and subsequently as the Senior Vice President, Care Chemicals North America at BASF Corporation. In 2024, he was appointed to his current role as President of BASF Asia Pacific (excluding China) & Non-Executive Director BASF India Ltd., based in Singapore. Christian began his career at Clariant in February 2008 as the regional Head of Asia Pacific. He has held several key positions within the organization. In 2022 he was appointed President for Care Chemicals & Americas and Member of the Executive Steering Committee. 공시 • Oct 30
Clariant AG Confirms Earnings Guidance for the Year 2025 Clariant AG confirmed earnings guidance for the year 2025. For the year, the company expected local currency sales growth at the lower end of the 1% to 3% range . 공시 • Oct 25
Clariant AG Announces Board Members Not Standing for Re-Election on April 1, 2026 Clariant AG announced that the Board of Directors decided to reduce its size from eleven to eight members, right-sizing the Board to align with Clariant’s streamlined operations and addressing investor concerns on independence, tenure and gender diversity. In support of these efforts, five directors, Roberto Gualdoni, Geoffery Merszei, Eveline Saupper, Peter Steiner, and Konstantin Winterstein will not stand for reelection at the 2026 AGM on 1 April 2026. The Board will propose two new, independent Board members to the shareholders as appropriate ahead of the 2026 AGM. 공시 • Oct 03
Clariant Rejects Allegations from BP Europe and ExxonMobil Against Four Companies Related to the 2020 Competition Law Infringement Clariant announced that on 02 October 2025, the company received two claims for damages against four companies, including Clariant, from BP Europe SE and ExxonMobil Petroleum & Chemical B.V. with the court of Munich and Dortmund respectively, both in Germany. The claims claims totaling to around EUR 1.1 billion and EUR 860 million respectively, in relation to infringement of competition law on the ethylene purchasing market which was sanctioned by the European Commission in July 2020. Clariant firmly rejects the claims and will adamantly defend its position in the proceedings. Clariant has substantiated economic evidence that the conduct of the parties did not produce any effect on the market. 공시 • Sep 22
Clariant AG(SWX:CLN) dropped from FTSE All-World Index (USD) Clariant AG(SWX:CLN) dropped from FTSE All-World Index (USD) Reported Earnings • Aug 04
First half 2025 earnings released: EPS: CHF0.079 (vs CHF0.48 in 1H 2024) First half 2025 results: EPS: CHF0.079 (down from CHF0.48 in 1H 2024). Revenue: CHF1.98b (down 4.3% from 1H 2024). Net income: CHF26.0m (down 83% from 1H 2024). Profit margin: 1.3% (down from 7.6% in 1H 2024). Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Germany. 공시 • Jun 03
Clariant AG to Report Q4, 2025 Results on Feb 26, 2026 Clariant AG announced that they will report Q4, 2025 results on Feb 26, 2026